ResearcherUniversity of Central FloridaNo recent work listed

Sarah B. Gitto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6496-4528; OpenAlex author ID A5066032846. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Induction of pancreatitis in mice with susceptibility to pancreatic cancer. Co-author DOI 10.1016/bs.mcb.2021.12.013 ↗
Difluoromethylornithine Combined with a Polyamine Transport Inhibitor Is Effective against Gemcitabine Resistant Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.7b00718 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Deborah A. Altomare · 2 shared papers, 2018–2022 · strength 0.29
- Paper Induction of pancreatitis in mice with susceptibility to pancreatic cancer. DOI 10.1016/bs.mcb.2021.12.013 ↗
- Paper Difluoromethylornithine Combined with a Polyamine Transport Inhibitor Is Effective against Gemcitabine Resistant Pancre… DOI 10.1021/acs.molpharmaceut.7b00718 ↗
Otto Phanstiel · 1 shared paper, 2018 · strength 0.09
- Paper Difluoromethylornithine Combined with a Polyamine Transport Inhibitor Is Effective against Gemcitabine Resistant Pancre… DOI 10.1021/acs.molpharmaceut.7b00718 ↗
Veethika Pandey · 1 shared paper, 2018 · strength 0.09
- Paper Difluoromethylornithine Combined with a Polyamine Transport Inhibitor Is Effective against Gemcitabine Resistant Pancre… DOI 10.1021/acs.molpharmaceut.7b00718 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.